Skip to content

Viatris VTRS PEG ratio

PEG ratio at other companies

McKesson logo
McKessonMCK
0.5×-2.1×
Cencora logo
CencoraCOR
13.6×+11.2×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
2.1×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.2×
Biogen logo
BiogenBIIB
0.4×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$17.9B+49.6%
Enterprise value$30.71B+17.7%
P/S1.2×+0.4×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Calculated from Viatris’s reported figures.

Based on the most recent quarter.

The official record: Viatris’s 10-Q, filed November 7, 2024, on SEC EDGAR. View the filing →

Ask your AI about Viatris's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's PEG ratio?
Viatris (VTRS) reported PEG ratio of 0.1× in Q3 2023.
What does PEG ratio mean?
The P/E ratio adjusted for how fast earnings are growing.
How do you interpret PEG ratio?
Around 1.0 is often cited as fairly valued for the growth on offer; below 1.0 can flag a growth bargain. Highly sensitive to the growth input and meaningless when growth is zero or negative.
How does PEG ratio compare across companies?
A rough cross-company growth-adjusted screen; treat as directional given its sensitivity to the (trailing) growth basis.